27.02.2020 14:36:23
|
Fighting The Deadly Coronavirus
(RTTNews) - The new coronavirus, COVID-19, which originated in China, has now spread to least 47 countries, infecting over 81,000 people and killing 3,000 people, with the majority of them in China.
A report released by the World Health Organisation on February 25, 2020, says "for the first time, since the onset of symptoms of the first identified case of COVID-19 on December 8, 2019, there have been more new cases reported from countries outside of China than from China."
A number of companies have joined the hunt for a treatment to tackle the new coronavirus. Nearly 124 studies have either commenced or are expected to do so shortly, with all but three taking place in China, STAT News reported sourcing the information to Informa Pharma Intelligence.
Let's take a look at some of the companies in the race to test Coronavirus drug.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Vaxart Inc Registered Shsmehr Nachrichten
12.11.24 |
Ausblick: Vaxart gewährt Anlegern Blick in die Bücher (finanzen.net) | |
07.08.24 |
Ausblick: Vaxart stellt Ergebnisse des abgelaufenen Quartals vor (finanzen.net) |
Analysen zu Vaxart Inc Registered Shsmehr Analysen
Aktien in diesem Artikel
Co-Diagnostics Inc Registered Shs | 0,83 | -2,92% | |
AbbVie Inc | 173,54 | 0,08% | |
Bio Blast Pharma Ltd. | 1,04 | -0,95% | |
Gilead Sciences Inc. | 87,58 | -0,07% | |
Johnson & Johnson | 146,70 | -0,14% | |
Regeneron Pharmaceuticals Inc. | 708,00 | -1,64% | |
Vaxart Inc Registered Shs | 0,56 | 0,09% |